Screener
OraSure Technologies OSUR Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Net revenues by Product | ||||||
| COVID-19 | $1K-96.4% | $18K-96.1% | $13.18M+29.4% | $89K-95.9% | $28K-96.5% | |
| HCV | $3.39M-17.8% | $2.66M-38.5% | —— | $2.6M-19.3% | $4.13M-67.3% | |
| HIV | $14.17M-1.6% | $13.02M+0.9% | $11.36M-26.3% | $11.14M-39.3% | $14.4M-24.0% | |
| Other | $915K-34.4% | $1.55M+65.8% | $1.89M+786% | $1.75M+563% | $1.4M+261% | |
| Other Product And Services Revenues | $2.29M+130% | $1.62M+109% | —— | $1.2M0.0% | $994K-56.9% | |
| Risk Assessment Testing | $0-100% | $0-100% | $0-100% | $0-100% | $446K-90.6% | |
| Sample Management Solutions | $9.88M+0.2% | $9.06M-0.6% | $9.09M-38.7% | $10.31M-19.5% | $9.86M-27.8% | |
| Net revenues by Geography | ||||||
| Africa | $6.79M-15.5% | $6.77M-5.8% | $4.97M-46.6% | $4.88M-57.1% | $8.03M+26.1% | |
| Europe | $1.74M-17.7% | $1.45M-11.5% | $2.33M-8.0% | $1.3M-38.9% | $2.12M-2.2% | |
| Other regions | $1.88M+50.5% | $1.03M+33.8% | $1.28M-15.0% | $1.25M+17.7% | $1.25M-12.2% | |
| United States | $20.24M+1.9% | $18.67M-8.2% | $18.18M-24.6% | $19.66M-22.4% | $19.85M-55.3% |
FAQ
- How does OraSure Technologies break its business down?
- OraSure Technologies (OSUR) reports net revenues by product across 7 parts — COVID-19, HCV, HIV, Other and Other Product And Services Revenues. Each is extracted from the segment footnotes and tracked over time.
- Where does OraSure Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in OraSure Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
